HOME >> BIOLOGY >> NEWS
Hutchinson Center to lead $11.5 million ovarian-cancer research consortium

member of the Hutchinson Center's Human Biology and Clinical Research divisions.

Established by Congress in 1992, the organ-based SPORE Program was created to promote collaboration between basic and applied scientists to speed the testing of new approaches to the prevention, early detection, diagnosis and treatment of a variety of cancers. While previous SPORE programs have existed for breast, prostate, lung and gastrointestinal cancers, this is the first time the NCI has directed SPORE funding toward ovarian cancer.

A major strength of the Pacific Ovarian Cancer Research Consortium is its history of interdisciplinary collaboration in ovarian-cancer research. "We have a track record of working together," Urban says, referring to a working group of ovarian-cancer researchers throughout Seattle that has met every two weeks for the past two years. "Our interdisciplinary collaboration is real; it's not just on paper," says Urban, who also directs the Marsha Rivkin Center for Ovarian Cancer Research in Seattle, a "center without walls" that is jointly sponsored by Swedish Medical Center and the Hutchinson Center. (Coincidentally, today's announcement falls on the sixth anniversary of the death of Marsha Rivkin, who in 1994 died of ovarian cancer at age 49, leaving five daughters as well as her husband, Saul Rivkin, M.D., a medical oncologist at Swedish Medical Center.)

The Consortium has three major goals: the first is gene discovery, from which all else flows. The second is translational research, finding innovative ways to use newly discovered genes and gene products in cancer prevention, early detection and treatment. The third is outcomes research, which ensures that the Consortium's efforts are invested in strategies that yield the greatest reductions in ovarian-cancer incidence and mortality. The outcomes research also will focus on making substantial improvements in quality of life among women
'"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
4-Oct-1999


Page: 1 2 3 4 5 6

Related biology news :

1. Intel and Fred Hutchinson to explore the use of nanotechnology tools for early disease detection
2. American Association for Cancer Research honors Fred Hutchinson Cancer Research Center investigator
3. Fred Hutchinson Cancer Research Center, University of Washington join in national effort to study health impact of toxic substances
4. Hutchinson Center researchers first to induce state of suspended animation in model vertebrate organism
5. Digging for genetic fossils: Hutchinson Center researchers solve structure of ancient biological molecule
6. Fred Hutchinson Cancer Research Center to lead international team to accelerate investigation of immune-related genes
7. Hutchinson Center researcher awarded Block lectureship
8. White House honors Hutchinson Center Scientist with Presidential Early Career Award
9. Fred Hutchinson Cancer Research Center researcher one of five awarded $1 million distinguished young scholars grant
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Hutchinson Center Director Wins Americas Nobel

Post Your Comments:
(Date:7/24/2014)... is available in German . ... 300 million asthma sufferers worldwide, a further 600 million ... of the global population contending with allergic rhinitis (allergic ... also affect other organs and parts of the body ... intestine (in the form of inflammatory bowel diseases such ...
(Date:7/24/2014)... is available in German . ... recognize and respond to threats to health, and to ... understanding of the mechanism underlying immunologic memory, however, has ... converged to support the hypothesis that the persistence of ... with stem-cell-like potential. Until now, there was no conclusive ...
(Date:7/23/2014)... of identical twins has found that early reading skill ... the journal Child Development , was conducted by ... London. , "Since reading is an ability that can ... according to Stuart J. Ritchie, research fellow in psychology ... "Early remediation of reading problems might aid not only ...
Breaking Biology News(10 mins):New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3Stronger early reading skills predict higher intelligence later 2
(Date:7/24/2014)... July 24, 2014 Research and Markets ... Genomics and Proteomics Analytical Instruments Market 2014-2018" report ... Genomics is the study of the ... of the structure and functions of proteomes or sets ... and technology. Genomics involves the mapping of genes and ...
(Date:7/24/2014)... 24, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... notice on July 18, 2014 from the NYSE ... the CorMedix plan to regain compliance with continued ... the NYSE-MKT is continuing the Company,s listing and ...
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
(Date:7/24/2014)... Toronto, Canada (PRWEB) July 24, 2014 ... for Optimizing Dose Escalation in First in Human Studies” ... to make better go/no-go decisions. , With increasing R&D ... market, pharmaceutical companies need to maximize the knowledge collected ... go/no-go decisions and improve success in late stage development. ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
Cached News: